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1. Introduction 
It has been long reported that for children with end-stage renal disease (ESRD), renal 
transplant is the treatment of choice (Fine et al., 1978; Gradus & Ettenger, 1982). With this 
approach the lost renal function is reestablished and the pondo-stature, psycho-intellectual 
and social development is not affected (Ferraris & Rodriguez, 2008). 
Hemodialysis or ambulatory peritoneal dialysis are modalities used in the treatment of 
children with ESRD when there is no living donor available or when patients are waiting for 
a cadaver donor (Galvez et al., 2005). However, these patients will eventually present 
growth and intellectual development alterations. 
In 1954 Murray performed the first truly successful pediatric kidney transplant from one 
homozygous twin to another (Murray et al., 1958). In 1966 Kelly reported a kidney 
transplantation in a patient with dysfunctional bladder who had undergone ileal segment 
urinary diversion (Kelly et al., 1966). Until that time, patients with ESRD and untreatable 
dysfunctional urinary tract were excluded from renal transplant programs. At that time, it 
was believed that the renal allograft connected to a dysfunctional bladder would run the 
same risk as the native kidneys, that is, the result would be again renal insufficiency 
(Sheldon et al., 1994). 
As a consequence, the focus began to be placed on the restoration of the dysfunctional lower 
urinary tract with the aim of creating urinary reservoirs of adequate volume and low 
pressure that could have complete voiding capacity (Mitchell & Piser, 1987). At present, 
children with ESRD can benefit from renal transplantation provided the lower urinary tract 
dysfunctions are corrected or reestablished by means of medical and/or surgical treatment 
(Broyer et al., 2004). Otherwise, the bladder dysfunction that is not corrected would have a 
negative effect on the allograft function (Salomon et al., 2000). 
Several studies reporting long term encouraging results on patients that have received 
kidney transplantation with urinary tract reconstructions have been published. However, 
higher risks and incidence of complications related to the allograft and reconstruction have 
also been informed (Shekarris et al.,2000). Despite these risks, Luke obtained comparable 
and acceptable results in children with reconstructed urinary tract, similar to the renal 
transplanted subjects that had normal lower urinary tract function, following a careful pre-
transplant evaluation and an appropriate post-transplant follow-up (Luke et al., 2003)  
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Nevertheless, there exists considerable controversy around the best approach to handle 
these types of patients, since there are no guidelines designed with defined reconstructive 
surgical criteria, optimal surgical procedures or recommendations as to when the best time 
to perform such interventions (Riley et al.,2010). 
2. Etiologies for end stage renal disease – Uropathies 
Among the most frequent etiologies for end stage renal disease are renal hypodysplasia 
(17%), obstructive uropathies (16.9%), focal segmental glomerulosclerosis (9%), 
vesicoureteral reflux (6.3%), renal polycystosis, uremic hemolitic syndrome, Prune belly, 
neurogenic bladder due to neural tube defects, among others (North American Pediatric 
Renal Transplant Cooperative Study (N.A.P.R.T.C.S.), 2007)  
The predominance of one or other etiology is conditioned by the different geographical 
regions. The deterioration of the renal function is not the most common consequence of 
vesicoureteral reflux (VUR), with an estimated risk lower than 1%. There is a direct 
relationship between the degree of VUR and the incidence of the nephropathy (Skoog et 
al, 1987). Up to 35% of renal scarring is congenital, due to dysmorphic renal tissue from 
the gestational stage, especially in high degree VUR. When there is vesicoureteral reflux 
the patient is prone to develop pyelonephritis, and if this occurs during the first months of 
life or in repeated fashion, there are more chances of developing renal scars and 
aggravating the renal function. The incidence of chronic pyelonephritis is within 15 and 
25% of ESRD.  
The term ‘obstructive uropathies’ includes entities such as pyeloureteral stenosis, 
ureterovesical stenosis, obstructive megaureters and prior surgically corrected obstructive 
uropathy remnants. All these uropathies manifest as hydronephrosis or 
ureterohydronephrosis. The obstruction to the urine flow, if not corrected, eventually 
produces irreversible reduction of the function, depending on whether the obstruction is 
bilateral, affects only one kidney or an insufficient one (Podestá & Bertolotti, 2008).  
Posterior urethral valve (PUV) remains the most frequent organic-anatomical obstruction in 
males and it is due to a congenital defect in the development of the membranous urethra. 
This condition can manifest along a spectrum of severity, ranging from disease incompatible 
with postnatal life to conditions that have minimal impact later in life. Chronic obstruction 
of the outlet urinary tract during the critical stage of organogenesis of the urinary system 
exerts a deep impact on the kidneys, ureters and vesical function. Approximately a third of 
the patients with PUV progress to ESRD (López & Durán, 2008).  
In the case of Prune belly syndrome the kidneys may exhibit: ureterohydronephrosis, 
VUR, renal dysplasia, anatomical infravesical obstruction. This syndrome has a broad 
spectrum of affected anatomy with different levels of severity, from incompatibility with 
life to minimally compromised renal function (Woodward & Smith, 1998). Many patients 
require multiple urological surgeries with some cases of irreversible deterioration in the 
renal mass.  
Patients with a neurogenic bladder caused by spinal dysraphism that do not receive 
appropriate treatment can progress to ESRD (De Jong et al., 2008). Spinal dysraphism 
abnormalities mainly include myelomeningocele, lipomeningocele and caudal regression 
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syndrome. All of them generate different types of behavior of the neurogenic bladder and 
particularly affect the renal function (Torre et al., 2011). 
The urodynamic variables that are more involved as risk factors are: detrusor hyperactivity, 
reduced compliance, detrusor-sphincter dyssinergia.  
Medical therapies implemented during the first months of life and sustained by 
anticholinergic drugs and clean intermittent catheterization greatly help to avoid 
compromise or deterioration of the renal function.  
3. Evaluation of the urinary tract 
There is general consensus among the most prominent health care centers that assessment of 
the lower urinary tract before performing a renal transplant is of the utmost importance. If 
alterations are found, they must be corrected before the allograft is implanted. A 
dysfunctional lower urinary tract that has promoted the deterioration of the native kidneys 
represents a risk for the allograft.  
In the first place, a history of baseline pathologies and a thorough physical examination are 
fundamental, since they determine which complementary studies will be needed. It is not 
necessary to have all patients undergo all possible urological studies. For that reason it is 
useful to define beforehand whether ESRD was caused by a nephropathy or by an uropathy. 
If the latter applies, it is necessary to classify patients into two groups: those who did not 
require urinary tract surgery and those who did.  
Overall, for the group of patients who required lower urinary tract surgery most of the 
complementary studies described below will be needed. When the signs and symptoms 
reported by patients or parents are not clear enough, especially with respect to urinary 
incontinence or alterations of the voiding frequency, keeping a voiding diary and a record of 
urinary leakage becomes very useful. 
On occasions, when the history or symptoms of urologic pathology are not defined, we 
must resort to other specialties for further evaluation, such as neurology-neurosurgery, in 
order to search for the etiological diagnosis of certain urinary dysfunctions.  
The physical examination also includes the assessment of the abdominal and pelvic region 
for position of dialysis catheters, intestinal and urinary stomas, either for possible 
reconstructions of the urinary tract or to locate a future allograft implantation. In addition, it 
is necessary to analyze the status and mobility of lower and upper limbs, with the purpose 
of deciding whether intermittent catheterization could be used for bladder voiding, via the 
urethra or via continent stoma. 
Ultrasound scanning is the initial technique of choice in order to detect morphological 
abnormalities. Although it is operator/observer-dependent, it does not present any 
contraindications and it can be repeated as many times as necessary without having 
damaging effects on the patient (Bibiloni, et al., 2008). In ESRD, ultrasound is used in order 
to characterize degree of ureterohydronephrosis, double ureter systems and characteristics 
of the vesical wall. If diuresis exists, ultrasound scanning with full and empty bladder is 
required in order to evaluate if there is post void residual or ureterohydronephrosis 
alterations.  
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Voiding cystourethrogram is mandatory, especially in the case of patients with a history of 
urinary infections and lower urinary tract surgeries. It is an irreplaceable method to detect 
vesicoureteral reflux, to show anatomical details of the bladder neck, of the male urethra, 
and to characterize other findings, such as bladder stones and irregularities of the bladder 
wall. This methodology also provides information on voiding pathophysiology. As it is an 
invasive procedure that uses fluoroscopy radiation, it must be carried out by trained 
professionals, so that the method can be optimized.  
Urodynamic studies record the activity of the lower urinary tract in the filling and voiding 
phases of the bladder. The variables recorded, such as volume, bladder pressure, urinary 
leakage pressure, bladder compliance, detrusor muscle stability, coordination of the cycle, 
perineal surface electromyography activity, among others, determine the type of bladder 
dysfunction and help to indicate the most appropriate treatment and to control the 
evolution and therapeutic response (Burek & Sager, 2008). Urodynamic studies are required 
when there is a history of spinal dysraphism and other etiologies of neurogenic bladder, 
posterior urethra valves, lower urinary tract surgeries, urine incontinence, therapy with 
anticholinergic drugs, anatomical alterations as shown in the voiding cystourethrogram and 
high degree of vesicoureteral reflux.   
In the latter case, a video urodynamic study is the preferred method, since it combines the 
benefits of voiding cystourethrography and urodynamic records. This results in a thorough 
anatomic and functional evaluation of the urinary tract. The video urodynamic study 
requires a certain degree of technical complexity and it must be performed by very well-
trained professionals. In the case of some patients, in order to simplify and reduce 
manipulation, the following algorithm can be applied: renovesical ultrasound and video 
urodynamic study ( Cerruto & Artibani, 2006). 
4. Adequate bladder function 
The urinary tract can be described as being “functional” if the storage and voiding phases of 
the bladder function in a coordinated way. In the first phase, the pelvis and ureters must 
void an adequate volume of urine into a bladder or neobladder of low pressure without 
leaks. Competent ureterovesical junctions stop urine from refluxing into the upper urinary 
tract. During the voiding phase, the bladder muscle (detrusor) contracts at regular intervals 
and in a sustained fashion, with relaxation of the outlet urinary tract (bladder neck and 
sphincter) with the purpose of eliminating urine. Many patients cannot achieve normal 
voiding and require clean intermittent catheterization.  
After evaluation is completed we must define whether the lower urinary tract is in good 
condition to receive an implant. The parameters used to define “adequate bladder function” 
are:  
- Absence of signs and symptoms of low urinary tract dysfunction. 
- Absence or scant post void residual urine on renovesical ultrasound. 
- Adequate volume capacity and bladder compliance, stability of the detrusor muscle, 
adequate voiding, no post void residual and no leaks as assessed by urodynamic/video 
urodynamic studies ( Barry, 2004).  
If assessment outcome shows that the lower urinary tract is not in adequate condition to 
receive a new kidney, therapy customized to the particular urologic condition should be 
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indicated and a new evaluation should be carried out prior to transplantation. If 
reconstruction of the lower urinary tract is to be performed, the objective is to achieve a 
functional urinary tract.  
5. Treatments for the lower urinary tract 
5.1 Medical treatments 
The objective of any treatment is to provide a safe mechanism of drainage for those patients 
who have voiding difficulties, by means of clean intermittent catheterization (CIC) and 
pharmacological reduction of storage pressure or non-inhibited contractions with the use of 
anticholinergic drugs.  
CIC is the most significant advancement in the urological care of patients with neurogenic 
dysfunction of the lower urinary tract. This procedure provides adequate voiding and a 
reduced risk of urinary infections; it helps to avoid bladder overdistension; it facilitates 
resolution of the vesicoureteral reflux and favors urinary continence. CIC may be performed 
at any age, on both sexes and at any position and site. It can be indicated in the presence of 
high intravesical pressure, detrusor-sphincter dyssynergia, sphincter hypertonia, high 
residual urine volume and absence of spontaneous voiding. It is fundamental that 
instruction of the procedure be in charge of trained nurses, who will also supervise CIC 
management periodically.  
CIC is a safe, easy and effective way of emptying the bladder with a low rate of 
complications. Although unusual, the most frequent complications are urethral bleeding 
and false passages, and epididymitis. Asymptomatic bacteriuria is observed in 70% of 
patients, but it is not associated to renal scarring; therefore, it is not treated. Antibiotic 
prophylaxis is indicated only at the beginning of CIC to patients with vesicoureteral reflux 
and those who have received a renal transplantation.  
Anticholinergic drugs, mainly oxybutynin, are used for the treatment of hyperreflexia and 
bladder hypertonia. They are widely used in pediatric settings; they are of acceptable 
tolerance and they have proved to provide a beneficial therapeutic effect. For those patients 
who do not tolerate oxybutynin, tolterodine can be used. It is more selective; it has fewer 
adverse effects, but does not seem to have more efficacy. Other even more selective drugs, 
such as darifenacin, are also being used lately in the pediatric population.  
The selective alpha-adrenergic blockade is a therapeutic alternative in cases of dysfunctional 
voiding of different etiologies. It facilitates the release of infravesical outflow obstruction. 
Doxazosin is one of the most commonly used drugs (Austin et al., 1999) Biofeedback 
therapy, mainly used with patients with non-neurogenic bladder dysfunction, contributes to 
educating, relaxing the perineum region and improving the dynamics of the detrusor-neck-
sphincter unit. 
5.2 Surgical treatment  
5.2.1 Reconstruction of the urinary tract in children 
The aim of the surgical intervention/s is to reestablish a new system that can protect the 
renal function and achieve adequate urine volume at low pressure, avoid urinary infections 
and lead to continence.  
www.intechopen.com
 
Renal Transplantation – Updates and Advances 218 
At present, most of the reconstructive procedures are performed in order to correct 
anomalies of the native urinary tract refractory to medical treatment. Children with bladder 
and sphincter dysfunction represent a big challenge and most patients who require 
reconstructive procedures have myelodysplasia as etiology for the neurogenic bladder.  
The pathophysiological ways that lead to dysfunction of the excretory system are manifold; 
therefore, the evaluation of reconstruction should be meticulous and individualized. In 
addition to technical surgical matters, in questions of evolution and outcome it is important 
to consider the commitment of the patient and the family in the monitoring and post-
surgery care. When a reconstruction of the lower urinary tract is considered, the aim is to 
achieve the characteristics of a functional urinary tract.  
In general, vesicoureteral reflux is secondary to bladder dysfunction. In other etiologies, 
such as Prune belly syndrome and posterior urethra valves, the reflux can be primary and 
secondary. In the case of secondary reflux of low degree in patients that will undergo 
bladder augmentation, it is not necessary to correct the reflux, since after the augmentation, 
this type of reflux may resolve without the need for reimplantation. If the reservoir has 
adequate low pressure volume, reimplantation is not necessary. However, some surgeons 
prefer correction of the reflux, since they state that bacteiruria can unfold episodes of 
pyelonephritis.  
Furthermore, when thinking of reimplanting dilated ureters, it should be taken into account 
that sometimes they have fibrous walls, and tunnelization and aggressive remodeling can 
lead to ureterovesical obstruction. For patients suffering from ESRD with vesicoureteral 
reflux and ureterohydronephrosis, pre-transplant nephroureterectomy can be beneficial. If 
ureteral dilation comes first and the patient requires bladder augmentation, ureteral 
segments can be used for the reconstruction.  
The urothelium is exempt from complications that are inherent to intestinal segments 
(Nahas et al, 2004, Hitchcock, 1994). In this case, an extraperitoneal approach is taken: 
lumbotomy incision for the nephrectomy of the dysplastic kidney and mobilization of the 
dilated ureter and suprapubic incision for bladder augmentation. This approach is beneficial 
in that it avoids the risks of peritoneal adhesions, and it should be considered in the case of 
ventriculoperitoneal diversions and of patients who are still under ambulatory peritoneal 
dialysis (Bellinger, 1993; Dewan et al., 1994; Reinber et al., 1995; Wolf & Turzan, 1993). 
Ureterocystoplasty that is laparoscopically assisted has been used since a few years ago. No 
serious complications have been reported with the use of this procedure, although the need 
for reaugmentation has been informed to a high degree in the case of native bladders with 
severely reduced compliance. It is thought that the best candidates to receive 
ureterocystoplasty have moderately reduced compliance (> 20 ml/cmh2o) and available 
ureter of a diameter greater than 15 mm to be used in the reconstruction (Husmann et al., 
2004) 
When it is not possible to obtain urothelial tissue for bladder augmentation, segments from 
the digestive tube are used: from the stomach, now hardly ever used, to bowel segments. 
The native bladder is preserved and, for a better anastomosis to the bowel segment, a 
sagittal incision is performed in order to divide it in two valves. The intestinal segment is 
open along its antimesenteric border in order to detubularize it and reconfigure it into 
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spherical shape thus achieving maximum volume per given surface area, blunting of 
intestinal contraction, and improving overall compliance and distensibility.  
In many health care centers, ileal segments are chosen to perform colocystoplasty (Nahas et 
al., 2007), whereas at Hospital de Pediatría Prof. Dr. J. P. Garrahan and since several years 
ago, sigmoid colon segments without specific bowel preparation have been the segments of 
choice. No significant infection complications have been observed postoperatively. We have 
adopted the colon because of its proximity to the native bladder; it has a low rate of 
metabolic complications and no technical complications. 
It is necessary to train the patient and their family in the postoperative care of the 
colocystoplasty. This consists of clean intermittent catheterization, daily vesical washes and 
periodical visits to the urologist, because there is a certain risk of complications, such as 
symptomatic urinary infections, lithiasis, perforations and tumoral neoformations.  
Once a bladder or reservoir with adequate volume and low pressure is obtained, it is 
essential to resolve the urinary incontinence. One of the greatest technical challenges that 
the urologist surgeon faces in the reconstruction of the vesical neck is to be able to provide 
adequate outlet resistance. Especially in the case of the neurogenic bladder due to spinal 
dysraphism, bladder outlet is generally incompetent. There are many surgical options that 
include adjustments of the neck and proximal urethra thanks to the aponeurosis slings, 
creation of valve mechanisms, endoscopic injection of artificial volume-formation agents 
and artificial urinary sphincter.  
Several techniques that increase outlet resistance may also deteriorate the detrusor status, 
reducing its compliance or generating instability. These events will occur depending on the 
baseline pathology. Therefore, previous urodynamic evaluations carried out and a strict 
follow-up post-reconstruction and post-transplantation are the golden rule. The final option 
will undoubtedly be customized according to the baseline disease, the goals of the patients 
and technical limitations of medical nature.  
It is reasonable to say that clean intermittent catheterization may have been the most 
significant contribution in terms of reconstruction of lower urinary tract functions. The 
potential need or absence of need for CIC in every reconstruction should always be 
considered, and both patients and family must be updated as to the objectives of 
reconstruction as well as the importance of adapting themselves to long term CIC regimens 
in a strict way. In most cases, the CIC procedure will be needed and patients must learn 
about it and accept CIC before reconstruction.  
When the urethra is inaccessible, sensitive or carries irreparable obstructions, a tubular 
system with continence mechanism is built with the purpose of facilitating the access to the 
bladder or the reservoir. The Mitrofanoff principle (1980) solved this dilemma, thanks to the 
creation of a conduit, being the cecal appendix the most commonly used, reimplanted in the 
submucosal bladder tunnel at one extreme and converted into a catheterizable stoma at the 
other extreme, in the abdominal wall. When the bladder is full, optimal coaptation is 
achieved avoiding urine leakage. If it is not possible to use the cecal appendix, other tubular 
structures can be used, for instance the ureter, the Fallopian tubes or the reconfigured small 
intestine (Monti). It should be taken into account that complications that are not so 
infrequent, such as conduit stenosis, mucous prolapse and false passages, may occur. 
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5.3 Defunctionalized urinary tract: dry bladder 
Anuric children who are awaiting for a kidney transplantation deserve special attention. 
Patients without a relevant history of urologic disorders, in general patients with 
nephropathies, have a high probability of recovering the normal functional bladder 
parameters after the renal transplant, since their bladder has simply defunctionalized due to 
lack of diuresis. Thus, this alteration is reversible. 
On the other hand, patients with a history of neurogenic bladder or posterior urethra valves 
have a few chances of recovering, with the artificial bladder cycling or after the renal 
transplant, the adequate features of a functional urinary reservoir. In such cases, due to the 
chronic status of the baseline disease, the bladder walls suffer an important deposit of 
collagen connective tissue, with the subsequent reduction or lack of bladder compliance to 
accommodate increasing volumes of urine. Therefore, the urodynamic alterations are 
irreversible without an appropriate treatment after the renal transplant.  
Pre-transplant augmentation cystoplasty in anuric children can represent a problem if it is 
not appropriately controlled. The cumulus of intestinal mucus is the main enemy to 
manage. The lack of regular cycles/washes leads to the appearance of urinary infections, 
mucus plugs, development of lithiasis and risk of intestinal perforations. Three to four daily 
washouts with distilled water are recommended with the aim of achieving augmentation 
distension and eliminating the mucus. It is important to emphasize that the washout liquid 
must not contain mineral salts in order to avoid precipitates with intestinal mucus, which is 
an important factor involved in the lithogenesis. Finally, the urodynamic evaluation must be 
repeated prior to renal transplantation. 
5.4 Timing of reconstruction of the lower urinary tract 
The reconstruction of the lower urinary tract may be performed before, during or after 
kidney transplantation. Many authors claim that reconstruction must be done before 
transplantation (Ali-El-Dei et al., 2004; Nahas et al., 2004) on the assumption that the 
uropathy is directly responsible for ESRD and must be corrected; furthermore, as post-
transplant immunosuppression is far away in time from reconstruction, it will not affect the 
plastic procedures of the surgery (Fontaine et al., 1998).  
In general the reconstruction of the lower urinary tract before the renal transplantation is 
preferred, since in this way the complications related to the reimplanted ureter that could 
lead to the loss of the graft are reduced (Taghizadeh et al., 2007). It is worth considering that 
in already augmented bladders the surgery of the renal transplant may become technically 
more complex because of the special care needed to avoid damaging the vascular pedicle of 
the cystoplasty during reimplantation, with the consequent risk of cystoplasty necrosis 
(MacInerny et al., 1995). 
The lower urinary tract reconstruction performed simultaneously with renal transplantation 
has the main disadvantage of interference in the process of tissue remodeling after bladder 
augmentation, generated by steroid-based immunosuppression, which would increase 
tissue fragility. This would promote complications, such as perforations and urinary 
infections. The manipulation of bowel segments a short time prior to kidney implantation 
would lead to infection complications related to the allograft. Nevertheless, there exist 
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specific situations in which some patients would benefit from such an approach. That is the 
case of patients who at the moment of the transplant surgery present important 
vesicoureteral reflux to the native kidneys and a bladder with low capacity and high 
pressure. Then it would be advisable to consider nephroureterectomy of the native kidneys 
and the use of urothelium segments of dilated ureters for ureterocystoplasty immediately 
before the placement of the graft. In this way, the reconstruction of the lower urinary tract is 
resolved with adequate tissues, with a low rate of infection complications for the graft.  
The reconstruction of the lower urinary tract after the renal transplantation may be performed 
when the renal function is stable and immunosuppression has been reduced, in order not to 
interfere with the postoperative remodeling processes. The main advantage of this approach is 
that the lower urinary tract is reconstructed 'only' when the infection complications appear, 
which are related to the difficulties in urinary voiding. That is why it has been suggested that 
continent apendicovesicostomy of the Mitrofanoff type should be performed before renal 
transplantation, and augmentation cystoplasty, after the renal transplant, if necessary. Several 
reports describe acceptable outcomes in terms of complications, survival of the graft and the 
receptor, compared to the patients that have been operated on before renal transplantation 
(Sheldon et al., 1994; Thomalla, 1990; Nahas et al., 1997).  
However, there is evidence that lower urinary tract reconstructions post renal transplant 
may trigger a high incidence of complications (Barisi et al., 2002), including episodes of 
pyelonephritis. Another disadvantage of this approach is that the time needed to reduce the 
immunosuppression doses exposes the graft and urinary tract to risky situations, where the 
patient requires a quick surgical solution to a transplant that may be deteriorating but it is 
not possible yet to reduce the immunosuppression drug doses.  
Our team adheres to Taghizadeh, who concludes that augmentation cystoplasty ‘before’ the 
renal transplant is preferable, because the incidence of complications related to the 
transplanted ureter and loss of graft is reduced.  
6. Renal transplant – Surgical technique – Anesthetic questions 
A main part of the preparation of the living donor’s kidney is done in situ by the surgical 
team of the donor. In general, the cadaveric donor’s kidney requires major manipulation in 
order to be able to be implanted, in a procedure called bench surgery, where the dissections 
of perirenal tissues are performed, technical procedures are applied in order to prepare the 
blood vessels to be anastomosed and the kidney is irrigated with specific solutions.  
By means of Gibson technique or paramedian cut, the incision extends from the costal 
border to the pubis and into the retroperitoneal space of the iliac fossa. The choice of one 
side, right or left, over the other is determined by the availability of the left or right kidney, 
localization of peritoneal dialysis catheter, stomas and available vascular access. 
Anastomosis between renal artery and vein is performed with primitive ileac artery and 
vein or hypogastric ones, and sometimes inferior vena cava and aorta, in a terminal-lateral 
fashion, with continuous polypropylene sutures 7/0. The procedure is performed by a 
cardiovascular surgeon. 
In the case of small patients, weighing less than 15 kilograms, a transperitoneal approach is 
preferred, using midline incision, from the xyfoid appendix to the pubis, with release and 
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dissection of aorta and inferior vena cava. Anastomosis is also done in these vessels using 
continuous polypropylene sutures 7/0 (Madeiros-Domingo et al., 2005). 
Prior to declamping of the vessels for blood reperfusion of the graft, it is essential to maintain 
central venous pressure between 15 to 20 cmh2o, with the use of hematic, colloidal and 
crystalloid products. When reperfusion is done, the graft can sequester up to 300 ml of liquid 
volume; that is why it is important to keep substantial reposition of liquids post-clamping.  
If the size of the organ is considerable in relation to the recipient, it may displace de liver 
and diaphragm upwards, making breathing and venous return difficult due to obstruction 
of the inferior vena cava  (Madeiros-Domingo et al., 2005). 
On the contrary, when the kidneys to be transplanted are small or shorter than 6 cm, they 
can be implanted in unit fashion, with anastomosis of the distal extreme to the aorta and 
inferior vena cava of the recipient vessels in a terminal-lateral way, as a segment interposed 
with proximal and distal anastomosis (Madeiros-Domingo et al., 2005). 
Uretero-neo-cystostomy (ureterovesical reimplantation) is performed using extravesical 
Lich-Gregoire antireflux ureteroneocystostomy method (Lich Jr. et al., 1961). Some groups 
use intravesical reimplants, according to Politano-Leadbetter technique (Politano, 1958), and 
it is performed by a urologic surgeon. The former is preferred, since it is fast, does not 
require extra cystostomy or big ureteral length.  
In most cases in our series, and when it was possible, the ureter was reimplanted into the 
native bladder. When the ureteric reimplantation wass difficult or the ureter caliber small, a 
double J (pig tail) catheter was used and it is removed 6 weeks following transplantation. 
For the rest of the patients, a K33-like catheter was used up to the renal pelvis of the graft, 
with an exit site other than the incision site and it was removed 5-7 days after the surgical 
procedure. The systematic use of a ureteral tutor for all recipients has reduced the incidence 
of ureteral complications ( Pleass et al. 1995). 
In the case of patients with bladder augmentation, the ureteroneocystostomy technique is 
the same, although special attention should be taken not to interfere in the continent 
diversion site (Mitrofanoff) in order to avoid urine leakage.  
In all recipients, in order to guarantee a complete drainage of the bladder, vesical drainage 
through the urethra or by way of continent appendicovesicostomy (Mitrofanoff procedure) 
was established for 7 days, and drainage of the perirenal space was performed.  
7. Modifications of the lower urinary tract after the renal transplantation 
After re-evaluation during follow-up, there are cases in which for different reasons, such as 
course of the baseline pathology, alterations in the bladder behavior due to reconstructive 
procedures, inadequate management and care after reconstruction, among others, there 
appears a need for another reconstruction of the urinary tract in order to keep the features of 
a "functional urinary tract.” Thus, on some occasions bladder re-augmentations, continent 
apendicovesicostomies of the Mitrofanoff type or procedures in the neck and/or proximal 
urethra must be performed so as to treat urinary incontinence. There is approximately 3% of 
cases described in the literature that needed procedures in the lower urinary tract after renal 
transplantation, although they had undergone evaluation and surgeries previously to the 
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transplantation (Sager et al., 2011). This evidences that although we may think that 
everything that was done was enough, in surgical terms, the nephro-urologic follow-up 
show us that evaluation and follow-up are fundamental and many times it is necessary to 
do adjustments in order to protect the allograft.  
8. Graft survival 
Extensive bibliography shows that renal transplantation can be indicated safely in the case 
of patients with lower urinary tract reconstructions, achieving acceptable survival and 
function of the graft. The results are comparable to the ones obtained for patients with 
normal urinary tract (Franc-Guimond & Gonzalez, 2004; Capizzi et al., 2004).  
At Hospital Nacional de Pediatría Prof. Dr. J. P. Garrahan, 156 renal transplants have been 
performed up to date on children with uropathies, 38 of which received reconstructions of 
the dysfunctional urinary tract. No significant differences have been found between the 
latter and those patients that had no lower urinary tract reconstructions regarding survival 
of the graft or levels of creatininemia at year 1 and 5 after transplantation (Sager et al., 2011). 
In general terms, the actuarial global functional survival rate after the first year 
postoperatively was higher than 93%, and at year 5 it was between 75% and 85% (Figure 1) 
 
Fig. 1. Actuarial allograft survival in patients with uropathies. Group A: Patients without 
surgeries in lower urinary tract; Group B: Patients who underwent surgeries in lower 
urinary tract and preserved adequate bladder function; Group C: Patients who underwent 
surgeries in lower urinary tract due to inadequate bladder function. 
Other authors have shown that patients with dysfunction in the urinary tract that required 
reconstructions had an increased risk of complications and loss of the graft (Mochon et al., 
1992; Salomón et al., 1997). Such discrepancies can be explained because of the heterogeneity 
of the series published, the wide scope of the disease, the severity of the lower urinary tract 
and its different treatments (Riley et al., 2010) 
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9. Complications 
9.1 Vascular complications 
Vascular thrombosis is the third cause of loss of the graft in children according to the 
NAPRTCS (North American Pediatric Renal Transplant Cooperative Study), with an 
incidence of 11.6% (Benfield, 2003). When the receptor is very young and has a low weight, 
the risk increases because of the reduced diameter in the vascular structures. 
Vascular thrombosis, especially venous thrombosis, may occur immediately and up to 90 
days post-transplantation. It is a devastating complication, since besides the graft loss, it 
may unleash rupture of the graft capsule, major hematomas, massive hemorrhage, 
thromboembolic events and sepsis.  
Arterial thrombosis is the most feared, since it invariably conditions the loss of the graft and 
subsequent nephrectomy. In children its incidence is 6% (Singh et al., 1997). 
The causes of vascular thrombosis are intimal dissection, atherosclerosis, immunological 
factors and hypercoagulable state. Furthermore, high doses of cyclosporine or 
antilymphocyte globulin, systemic lupus erythematosus, antiphospholipid syndrome, and 
deficiency of protein C and S are involved.  
Arterial stenosis, with an estimated frequency of occurrence between 2% and 10% can 
appear during the post-transplant period or many years later, and it is localized at the site of 
anastomosis or distal to it. Immunological and mechanical factors generate a hyperplasic 
response of the intima. Arterial stenosis manifests as out of control arterial hypertension and 
deterioration of the function of the graft. This entity forces physicians to perform procedures 
such as transluminal percutaneous angioplasty with or without endovascular prosthesis or 
vascular bypass.  
Other vascular complications that are less frequent but not less severe are arteriovenous 
fistulas and perigraft hematomas or ureterovesical joint hematomas on the reimplantation 
site; the latter are also resolved surgically.  
9.2 Urologic complications 
Forced immunosuppression and complexity of the reconstructed urinary tract facilitate the 
appearance of different complications. By far, the most frequent bacteria infection in patients 
with a renal transplantation is the urinary tract infection (UTI) (Abbott et al., 2001; Karakayali 
et al., 2001). The incidence of UTI varies significantly across the literature: from 6% to 86% after 
renal transplantation. This variation responds to the different criteria in defining what UTI 
involves, the methods of urine collection and type of antibiotic prophylaxis, among others.  
The possible impact of UTI increases mortality and morbidity rates due to infection itself, 
and the potential effects on the processes of acute and chronic rejection. UTI episodes occur 
especially in the first postoperative stage, when the patient is hospitalized. A great 
percentage of UTI occurs between 6-12 months after the implant.  
Numerous risk factors for UTI are involved in renal transplantation; among the most 
important are the patients with a reconstructed lower urinary tract. The major causes are: 
anatomical conditions, characteristics of the intestinal mucus, vesicoureteral reflux and 
immunosuppression. Most of these patients who are under a clean intermittent 
www.intechopen.com
 
Pediatric Kidney Transplant in Uropaties 225 
catheterization program present with asymptomatic chronic bacteriuria. Reports have 
shown that this event has no effect on the survival of the graft (Warhom et al., 1999; Hatch et 
al., 2001). However, some authors believe that when pyelonephritis and recurrent episodes 
of asymptomatic UTI appear, the function of the graft is at risk, with the subsequent 
possibility of extirpation (Mendizabal et al., 2005; Alfrey et al., 1997). Other authors claim 
that recipients of the renal transplant with repeated UTI episodes show deterioration of the 
graft function, although its survival does not differ from the survival rate of the general 
population (Sullivan et al., 2003; Surange et al., 2003).    
In some reports, instituting an aggressive treatment for UTI at an early stage post-transplant 
is recommended, since UTI may trigger acute rejection (Sullivan et al., 2003); other reports, 
however, suggest that intensive treatment in the case of asymptomatic UTI may favor the 
development of resistant bacteria strains. In our center, the approach followed consists of 
using as antibiotic prophylaxis trimetropin/sulfametoxazol even in the presence of positive 
urocultures in asymptomatic patients, without alteration of the function of the graft. 
Intensive antibiotic therapy is reserved for those patients with symptomatic UTI, worsening 
of the renal function or the presence of aggressive germs such as pseudomonas aeruginosa 
or those related with lithogenesis, like proteus mirabilis.  
In our case report we showed that 25% of patients with renal transplantation and 
reconstructed urinary tract presented low UTI; 42.5% presented high UTI, and two patients 
developed sepsis of urologic cause; one of them with graft loss. Due to the detection of more 
episodes of UTI in this subgroup, vesicoureteral reflux was more frequently diagnosed 
(25%) compared to the subgroup of patients with uropathies without reconstructions, where 
reflux was observed in only 1% of the group (Sager et al., 2011). 
Vesicoureteral reflux to the graft, especially of high grade, which is associated to 
symptomatic UTI, is generally treated first with endoscopic approach. Different materials 
are used as endoscopic bulking agents in ureterovesical junction: the most common one is 
dextranomer/hyaluronic acid. Many times the endoscopic technique becomes difficult 
because the bladder has undergone previous surgery or augmentation, and the opening of 
the urethral meatus may not always be located. In cases of neurogenic bladders with 
vesicoureteral reflux to the graft and failure of the bulking agents, as the urinary tract has 
already been reconstructed, open ureterovesical reimplantation is very frequently done.  
If intermediate or low grade vesicoureteral reflux to the graft is detected under 
ureterohydronephrosis study and there are no UTI leaks nearby and the renal function is 
preserved, a vigilant attitude under antibiotic prophylaxis is taken before resorting to 
surgical techniques to resolve the reflux, provided the urodynamic studies do not show 
significant alterations.  
Ureterovesical stenosis may have an incidence between 2% and 4%. Different procedures 
can be required in order to reestablish the adequate urinary flow, such as pig tail catheters 
via percutaneous nephrostomy and posterior ureterovesical reimplant. Ureteral fistulas are 
produced by ischemic necrosis of the distal ureter, as a consequence of vascular lesion 
during donor nephrectomy. Hematoma of the ureterovesical juncture, urinary fistulas and 
necrosis of the distal ureter (2 to 4%) are directly associated as causative agents of 
ureterovesical stenosis and require in all cases open exploration (Sager et al., 2011). 
Perirenal collections are another frequent surgical complication with an incidence of 
approximately 49% (Pollak, et al., 1988). Lymphoceles cause several collections and are  
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generated by the cumulus of lymphatic liquid in the retroperitoneum, due to the dissection 
and binding of lymphatic vessels at the moment of forming the vascular pouch. Their 
occurrence has been associated to the use of Sirolimus (Giessing & Budde, 2003). Some 
lymphoceles may grow until displacing or comprising the reimplanted ureter, generating 
ureterohydronephrosis extrinsic to the implant. If the lymphocele grows progressively or is 
persistent, it may be treated by means of external percutaneous drainage or with 
laparoscopic exploration and marsupialization.  
Transplants    
n  
Group A  
68  
Group B  
48  
Group C  
40  
Complications      n(%)           
Vascular:           
   Arterial Stenosis  4(6)  2(4.2)  -  
   Arterial Thrombosis  2(3)  2(4.2)  -  
   Venous Thrombosis  1(1.5)  2(4.2)  1(2.5)  
   Arteriovenous Fistula  1(1.5)  -  -  
   Hematoma  1(1.5)  -  1(2.5)  
            
Urologic:           
   Ureterovesical Junction Hematoma  -  1(2)  -  
   Ureterovesical Stenosis  2(2.9)  2(4.2)  1(2.5)  
   Vesicoureteral Reflux (>grade II)  1(1.5)  1(2.1)  10(25)  
   Urinary Fistula - Ureteral Necrosis  2(2,9)  2(4.2)  1(2.5)  
   Renal Pelvis Necrosis  -  -  1(2.5)  
   Lymphocele  5(7.5)  2(4.2)  -  
   Vesical Lithiasis  -  -  2(5)  
   Retained drainage in surgical site  1(1.5)  -  -  
  Urinary Infections:     -  -  
       -Lower:  6(9)  3(6.2)  10(25)  
       -Upper:  8(12)  11(23.1)  17(42.5)  
   Sepsis of urologic origin  -  -  2(5)  
   Urinous Peritonitis  -  -  1(2.5)  
   Infection of surgical wound  1(1.5)  2(4.2)  6(15)  
   Abdominal wall abscess  -  -  2(5)  
   Urine Incontinence  -  -  1(2.5)  
Total n(%) 35(51.5)  30(63)  53(132) 
References: Group A: Patients without lower urinary tract; Group B: Patients that required surgery in 
lower urinary tract and preserved adequate bladder function; Group C: Patients that needed surgery in 
lower urinary tract due to inadequate function.  
Table 1. Vascular and Urologic Post Renal Transplant Complications in Patients with 
Uropathies. 
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Other causes of perirenal collections include: hematomas, urinomas and sera cumuli, all of 
which are not resolved unless surgical intervention is performed. 
Other urologic complications in decreasing order of presentation are: surgical wound 
infections, wall abscess, vesical lithiasis and urinous peritonitis due to colocystoplasty 
perforation.  
Recently, colocystoplasty neoformations –infrequent but of poor prognosis- have been 
reported as appearing several years after bladder reconstruction-augmentation. The exact 
etiopathogenic mechanism for these neoformations is unknown, but the possible 
explanations include: increased nitrosamines at the vesicointestinal anastomosis site; 
influence of disguised and chronic urinary infections, among others. At a histological level, 
the neoformations may be adenocarcynomas, urothelial tumors located in the native 
bladder, in the bowel segment or at the vesicointestinal anastomosis site, and in general they 
exert a very aggressive effect (Bono Ariño, et al., 2001). This poses a serious ethical-medical 
dilemma, since so far the established modality widely embraced has been the re-
functionalization of the lower urinary tract by means of intestinal segments in patients that 
will surely be put under immunosuppression regimens. Up to date, the only weapon to 
protect this complex subgroup of patients is a strict clinical, ultrasound and endoscopic 
follow-up, especially when hematuria is present.  
In our case report we describe the following complications and interventions post renal 
transplant (Tables 1 and 2). 
10. Vascular and urologic post renal transplant interventions  
 
Transplants  
n  
Group A  
68  
Group B  
48  
Group C  
40  
Vascular Interventions          
   Angioplasty  2  -  -  
   Bypass  1  2  -  
   Fistula embolization  1  -  -  
            
Urologic Interventions          
   Sigmoid vesical augmentation  1  -  2  
   Mitrofanoff  1  1  1  
   Mitrofanoff reoperation  -  1  2  
   Aponeurotic sling  -  -  1  
   Closure of bladder neck  -  -  1  
   Ureterovesical reimplant due to:           
      - vesicoureteral reflux  1  -  -  
      -Stenosis  2  1  1  
      -Fistula  2  2  1 
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Transplants  
n  
Group A  
68  
Group B  
48  
Group C  
40  
   Nephroureterectomy of native kidney  3  -  2  
   Drainage-punction of lymphocele  4  1  -  
   Drainage-punction of abscess-hematoma  2  -  2  
   Nephrostomy  3  1  3  
   Cystoscopy  2  -  -  
   Placement of pig tail catheter  2  1  3  
   Injection of substances due to vesicoureteral 
reflux  
-  -  1  
   Injection of substances due to urine incontinence -  -  1  
   Nephrectomy of the graft  5  2  4  
   Parcial Ureterectomy  -  2     
   Ureterostomy  -  -  2  
   Endoscopic Cystolitotomy  -  -  1  
   Open Cystolitotomy  -  -  1  
References: Group A: Patients without lower urinary tract; Group B: Patients that required surgery in 
lower urinary tract and preserved adequate bladder function; Group C: Patients that needed surgery in 
lower urinary tract due to inadequate function.  
Table 2. Vascular and Urologic Post Renal Transplant Interventions. 
11. Graft loss 
There are different causes of graft dysfunction, such as renal rejection and nephrotoxicity 
due to cyclosporine, tacrolimus and vascular problems. The vascular thromboses that are 
more associated to graft loss are venous thromboses. Urologic causes have infrequent 
relation to the renal graft loss, but recurrent urinary infections, such as pyelonephritis 
generate lymphocyte and intratubular neutrophilus deposits. As a consequence, but not 
exclusively due to pyelonephritis, the normal functional renal tissue is replaced by 
interstitial fibrosis and tubular atrophy (IF/TA). 
Even though the patients who have received a kidney transplantation and have corrected or 
reconstructed urinary tracts are subjected to an important incidence of urologic 
complications, the main cause for graft loss in our series was the presence of vascular events 
(Sager, et al., 2011). 
12. Survival and quality of life 
Survival rates at years 1 and 5 post-transplantation are 98.8% and 94.2%, respectively. In our 
series, 8 out of 150 patients died due to cardiovascular causes, lymphoproliferative disease 
and non urologic sepsis (Sager et al., 2011). 
In other studies, 100% of transplanted patients with over 10 years of follow-up reported that 
they feel they have good or excellent health status; 94% stated that their health status does 
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not interfere with their family and social life; 90% of them study or work; 70% have an active 
sexual life, and absence from their work or study places was in general minimal (Ferraris & 
Rodriguez, 2008). 
The success of this type of therapy also depends on “the patients’s adherence to treatment.” 
Lack of adherence is the most important risk factor for the development of chronic allograft 
nephropathy (CAN) and sub-clinical rejection. The critical period is when the adolescent 
goes from dialysis to the post-transplant phase, when the responsibilities as to being alert, 
managing care and decision-making increase.  
13. Follow-up 
Strict follow-up is essential in order to carry out a continuous assessment of the following 
aspects: function of the graft and drainage to the lower tract; function of the lower urinary 
tract; record of the urinary volume and frequency voided by means of voiding records; need 
for contrasting studies, such as cystourethrography and urodynamic studies.  
It is necessary to monitor compliance with medication therapy, for instance, anticholinergic 
drugs; compliance with daily bladder washes in the case of those who have undergone 
bladder augmentation, and the correct use of catheters for those who need catheterization 
via Mitrofanoff or urethra.  
It is likewise important to bear in mind that many patients and parents gradually lose 
interest in the urologic follow-up after the renal transplant. Thus, physicians should 
emphasize how essential monitoring is since the first consultation, so that parents, 
patients and medical caregivers become committed to a thorough and long-term follow-
up program.  
14. Conclusions 
Along the time, it has been demonstrated that the renal transplant is the best option for 
children with end stage renal disease. At present these children can benefit from this type of 
therapy provided the functions of the dysfunctional lower urinary tract are corrected, either 
by means of medical and/or surgical treatment. Otherwise, the bladder dysfunction that is 
not corrected will negatively affect the function of the graft.  
Among the most frequent etiologies for ESRD we can find renal dysplasia, obstructive 
uropathies, focal and segment glomerulosclerosis, nephropathy due to vesicoureteral reflux, 
renal polycystosis, hemolytic uremic syndrome, Prune belly, neurogenic bladder due to 
neural tube defects, and other conditions. All of them must be exhaustively evaluated so 
that it can be determined whether the lower urinary tract is in optimal condition to receive a 
renal implant, following the principle of "functional urinary tract." This term refers to the 
condition that a lower urinary tract should be a reservoir with adequate volume, low 
intravesical pressure and continence, and correct and complete urine voiding.  
For those cases that do not meet these criteria, different treatments are offered in order to 
provide a safe mechanism of drainage when voiding difficulties are present, via clean 
intermittent catheterization and pharmacologic reduction of filling pressure or contractions 
that are not inhibited, with the use of anticholinergic drugs.  
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When the objectives cannot be reached in spite of applying medical treatments, the option is 
surgical intervention for reconstruction of the urinary tract. Here the possibility of using 
urothelial tissues should be considered, since these patients usually have high grades of 
vesicoureteral reflux or obstructive ureterohydronephrosis. When it is not possible to obtain 
urothelial tissue to perform bladder augmentation, segments of the digestive tube can be 
used, either from the small or the large bowel, according to the criterion of each health care 
center.  
Favorable long term outcomes have been reported on patients who underwent renal 
transplantations with reconstruction of the urinary tract; however, there is considerable 
controversy around which is the best way to manage these patients, since there are no 
guidelines with defined criteria for reconstructive surgeries, optimal surgical procedures, or 
even recommendations as to when is the best time to do them.  
Our team adheres to Taghizadeh, whose report claims that augmentation cystoplasty before 
renal transplant is preferable, as the incidence of complications and graft loss is reduced, 
especially in relation to lesions of the transplanted ureter.  
It has also been agreed that renal transplantation can be indicated in a safe way to patients 
with lower urinary tract reconstructions, with acceptable survival and function of the graft. 
Results are comparable to those obtained in the case of patients with normal urinary tract. 
Nevertheless, it is undeniable that forced immunosuppression and the complexity of the 
reconstructed urinary tract favor the appearance of complications, especially infections 
related to the urinary tract. Potentially, this would promote the increase of morbidity and 
mortality rates and it would attempt against the implant. However, urologic causes have an 
infrequent relationship with the loss of the renal graft. 
In the case of these complex and heterogeneous patients, it is essential to provide a careful 
and individualized evaluation of the lower urinary tract prior to transplantation and a 
strict postoperative follow-up in order to diminish and control possible urological 
complications. Since at present there are no sound guidelines or protocols for the 
management of pediatric patients with dysfunctional lower urinary tract and end stage 
renal disease, it is necessary to design randomized multicenter studies in order to achieve 
better results on morbidity. 
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